Suriname

Suriname

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.66 (0.16 - 14.94) 2015 Modelled WHO
3.91 (2.97 - 5.14) 2013 Modelled Schweitzer et al, 2015
0.61 (0.50 - 0.70) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.68 (0.57 - 0.78) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.58 - 0.80) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.59 - 0.80) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.59 - 0.82) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.60 - 0.83) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.62 - 0.84) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.64 - 0.87) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.65 - 0.89) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.66 - 0.91) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.67 - 0.92) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.69 - 0.95) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.71 - 0.98) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.72 - 1.01) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.73 - 1.03) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.73 - 1.03) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.74 - 1.03) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.74 - 1.04) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.74 - 1.04) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.75 - 1.05) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.75 - 1.05) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.77 - 1.06) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.77 - 1.07) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.78 - 1.07) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.78 - 1.08) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.78 - 1.08) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.78 - 1.08) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.77 - 1.07) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.76 - 1.07) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.08) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.54 - 0.76) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.36 (0.03 - 3.84) 2015 Modelled WHO
0.04 (0.03 - 0.05) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.04 (0.03 - 0.06) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.06) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.06) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.06) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.07 - 0.13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.16) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.20) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.16 - 0.29) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.24 - 0.43) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.34 - 0.60) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.42 - 0.75) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.45 - 0.82) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.47 - 0.84) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.49 - 0.86) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.50 - 0.86) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.50 - 0.87) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.49 - 0.89) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.50 - 0.88) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.50 - 0.87) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.49 - 0.86) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.47 - 0.86) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.46 - 0.85) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.02 - 0.28) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
3,499 (2,875 - 4,055) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3,616 (2,995 - 4,189) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,769 (3,151 - 4,317) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,838 (3,211 - 4,390) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,846 (3,220 - 4,395) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,857 (3,194 - 4,439) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,886 (3,241 - 4,458) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3,955 (3,298 - 4,527) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4,030 (3,387 - 4,627) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4,085 (3,437 - 4,682) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4,088 (3,423 - 4,694) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4,102 (3,458 - 4,706) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4,177 (3,505 - 4,797) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4,262 (3,539 - 4,906) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4,317 (3,576 - 5,018) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4,298 (3,561 - 5,023) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4,230 (3,509 - 4,939) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4,158 (3,448 - 4,844) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4,081 (3,381 - 4,745) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3,999 (3,306 - 4,654) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3,911 (3,225 - 4,570) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3,832 (3,174 - 4,435) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3,775 (3,157 - 4,364) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3,730 (3,119 - 4,298) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3,682 (3,065 - 4,226) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3,623 (3,003 - 4,166) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3,562 (2,959 - 4,091) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3,522 (2,938 - 4,046) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3,488 (2,895 - 4,027) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3,445 (2,826 - 4,012) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3,397 (2,745 - 4,018) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.28 (1.66 - 3.06) 2019 Modelled IHME, GBD 2019 (accessed 2020)
4.05 (3.24 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.21 (3.30 - 5.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.29 (3.40 - 5.32) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.34 (3.25 - 5.58) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.54 (2.73 - 4.50) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.05 (3.14 - 5.11) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.21 (2.45 - 4.21) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.34 (2.54 - 4.34) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.25 (2.49 - 4.18) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.28 (2.54 - 4.23) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.13 (2.39 - 4.04) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.37 - 3.98) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.06 (2.32 - 3.94) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.06 (2.38 - 3.97) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.9 (2.25 - 3.74) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.31 - 3.87) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.89 (2.24 - 3.73) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.9 (2.27 - 3.74) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.28 - 3.79) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.26 - 3.80) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.27 - 3.83) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.20 - 3.69) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.04 - 3.43) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.92 - 3.20) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.78 - 2.97) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.69 - 2.91) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.25 (1.69 - 2.96) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.22 (1.71 - 2.90) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.27 (1.67 - 3.02) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.28 (1.66 - 3.06) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
50 2016 Modelled WHO
16 (13 - 19) 1990 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 20) 1991 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1992 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 1993 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 1994 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 1995 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 1996 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 18) 1997 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 1998 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 19) 1999 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2000 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2002 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2001 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2003 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2004 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2005 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2006 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2007 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2009 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2008 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 2010 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2011 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2012 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2013 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2016 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2014 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2015 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2017 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2018 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 18) 2019 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 18) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
20 (15 - 26) 1990 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 1991 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 25) 1992 Modelled IHME, GBD 2019 (accessed 2022)
18 (12 - 24) 1993 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 1994 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 21) 1995 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 1996 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2000 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2001 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 36) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
79 2019 Survey/reported WHO/UNICEF
79 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
80 2016 Survey/reported WHO/UNICEF
65 2015 Survey/reported WHO/UNICEF
64 2014 Survey/reported WHO/UNICEF
45 2013 Survey/reported WHO/UNICEF
51 2012 Survey/reported WHO/UNICEF
46 2011 Survey/reported WHO/UNICEF
41 2010 Survey/reported WHO/UNICEF
36 2009 Survey/reported WHO/UNICEF
69 2008 Survey/reported WHO/UNICEF
67 2007 Survey/reported WHO/UNICEF
64 2006 Survey/reported WHO/UNICEF
79 2020 Survey/reported WHO/UNICEF
79 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
77 2019 Survey/reported WHO/UNICEF
51 2020 Survey/reported WHO/UNICEF
72 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.95 (1.59 - 2.40) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.58 - 2.41) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.57 - 2.40) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.55 - 2.36) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.54 - 2.31) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.88 (1.53 - 2.31) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.53 - 2.30) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.52 - 2.30) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.52 - 2.30) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.50 - 2.30) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.50 - 2.30) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.50 - 2.28) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.49 - 2.29) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.49 - 2.29) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.48 - 2.29) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.49 - 2.29) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.51 - 2.32) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.52 - 2.35) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.53 - 2.38) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.54 - 2.41) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.55 - 2.41) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.55 - 2.41) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.56 - 2.42) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.57 - 2.43) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.56 - 2.44) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.56 - 2.43) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.55 - 2.43) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.54 - 2.41) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.54 - 2.42) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.53 - 2.41) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.52 - 2.30) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.55 (0.42 - 0.83) 2019 Modelled Dugan et al., 2021
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
7,150 (5,687 - 9,013) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7,200 (5,725 - 9,034) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7,257 (5,770 - 9,057) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7,308 (5,800 - 9,089) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7,384 (5,892 - 9,206) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7,515 (6,013 - 9,361) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7,670 (6,145 - 9,553) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7,833 (6,254 - 9,730) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7,998 (6,410 - 9,960) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8,170 (6,557 - 10,173) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8,350 (6,694 - 10,418) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8,513 (6,805 - 10,565) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8,650 (6,945 - 10,725) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8,769 (7,064 - 10,851) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8,881 (7,123 - 10,977) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9,003 (7,218 - 11,183) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9,136 (7,348 - 11,326) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9,253 (7,480 - 11,472) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9,363 (7,602 - 11,597) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9,473 (7,688 - 11,750) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9,614 (7,803 - 11,956) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9,770 (7,968 - 12,113) 2011 Modelled IHME, GBD 2019 (accessed 2022)
9,909 (8,080 - 12,222) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10,034 (8,175 - 12,360) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10,147 (8,264 - 12,434) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10,264 (8,332 - 12,610) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10,439 (8,484 - 12,902) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10,616 (8,654 - 13,192) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10,734 (8,733 - 13,274) 2018 Modelled IHME, GBD 2019 (accessed 2022)
10,768 (8,757 - 13,253) 2019 Modelled IHME, GBD 2019 (accessed 2020)
10,824 (8,809 - 13,323) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
820 (620 - 1,200) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
4.77 (3.35 - 6.58) 2019 Modelled IHME, GBD 2019 (accessed 2020)
4.55 (3.53 - 5.87) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.75 (3.68 - 6.10) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.84 (3.77 - 6.26) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.97 (3.68 - 6.55) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.71 (3.61 - 6.20) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.2 (3.10 - 5.50) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.05 (2.97 - 5.35) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.99 (2.91 - 5.28) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.1 (3.07 - 5.40) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.23 (3.25 - 5.59) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.1 (3.18 - 5.38) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.07 (3.13 - 5.32) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.04 (3.10 - 5.27) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.03 (3.10 - 5.30) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (3.02 - 5.12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (2.91 - 4.98) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (2.91 - 4.92) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (2.90 - 4.93) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (2.94 - 4.97) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.84 (2.96 - 5.01) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (2.92 - 4.97) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.84 (2.93 - 5.04) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.89 (2.95 - 5.13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.08 (3.10 - 5.40) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.23 (3.24 - 5.59) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.41 (3.37 - 5.86) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.53 (3.39 - 6.06) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4.64 (3.41 - 6.29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4.72 (3.40 - 6.44) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4.77 (3.35 - 6.58) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
21 2016 Modelled WHO
27 (19 - 38) 2019 Modelled IHME, GBD 2019 (accessed 2022)
27 (19 - 38) 2019 Modelled IHME, GBD 2019 (accessed 2020)
27 (20 - 37) 2018 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 36) 2017 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 34) 2016 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 33) 2015 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2014 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 30) 2013 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 28) 2012 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 28) 2011 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2010 Modelled IHME, GBD 2019 (accessed 2022)
20 (16 - 26) 2009 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2008 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2007 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 25) 2006 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 25) 2005 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 25) 2004 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2003 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 25) 2002 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 2001 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 24) 2000 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 1999 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 1998 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 1997 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 1996 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 1995 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 1994 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 26) 1993 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 1992 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 24) 1991 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
14 (10 - 20) 1990 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
14 (9 - 18) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 1995 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 16) 1994 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 10) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7 (4 - 9) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 10) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2017 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 10) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2018 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
22 (15 - 29) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.65 (%)
2019
(0.54 - 0.76(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
1.95 (%)
2019
(1.59 - 2.4(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
13
2019
(10 - 18)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
27
2019
(19 - 38)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.07 (%)
2020, latest modelled
(0.02 - 0.28(%))
WHO

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
79 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources